Central nervous system drugs

Application Famotidine has been used to test its effect on the human ether-a-go-go-related gene (hERG) binding transfected in HEK293 membrane. It has also been used in polycaprolactone based drug delivery studies.

Application Famotidine has been used to test its effect on the human ether-a-go-go-related gene (hERG) binding transfected in HEK293 membrane. It has also been used in polycaprolactone based drug delivery studies.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Biochem/physiol Actions Anticonvulsant agent that is an allosteric antagonist at the NR2B subunit of the NMDA glutamate receptor also has &#947-aminobutyric acid (GABA A ) receptor agonist properties.

Biochem/physiol Actions Anticonvulsant agent that is an allosteric antagonist at the NR2B subunit of the NMDA glutamate receptor also has &#947-aminobutyric acid (GABA A ) receptor agonist properties.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Felbamate is an antiepileptic drug used for the treatment of epilepsy, partial seizures in adults, and partial and generalized seizures associated with Lennox-Gastautsyndrome in children. The drug has a narrow therapeutic range and carries an

Legal Information CERILLIANT is a registered trademark of Cerilliant Corporation Snap-N-Shoot is a registered trademark of Cerilliant Corporation Snap-N-Spike is a registered trademark of Cerilliant Corporation

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Feline Chondrocyte Differentiation Medium Quality Each lot was tested for the ability to support plating, spreading and proliferation Preparation Note contained in protocol

Added to Basal Medium to create Growth Medium Quality Each lot was tested for the ability to support plating, spreading and proliferation Preparation Note contained in protocol